Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus

Surgical Endoscopy and Other Interventional Techniques

Volumn 22, Issue 12, 2008, Pages 2670-2678

  DePaula, A L ^a,b   Macedo, A L V ^c   Rassi, N ^d   Vencio, S ^b   Machado, C A ^b   Mota, B R ^b   Silva, L Q ^b   Halpern, A ^e   Schraibman, V ^c  

^a Hospital de Especialidades ^*  (Brazil)

^b HOSPITAL DE ESPECIALIDADES   (Brazil)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^d HOSPITAL GERAL DE FORTALEZA   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Arterial hypertension; Cardiovascular disease; Diabetes; Dyslipidemia; Ileal interposition; Metabolic syndrome

Indexed keywords

HIGH DENSITY LIPOPROTEIN; INSULIN; ORAL ANTIDIABETIC AGENT;

ABDOMINAL ABSCESS; ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; GASTRECTOMY; GASTROINTESTINAL HEMORRHAGE; GLYCEMIC CONTROL; HEART ARRHYTHMIA; HEMATOMA; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; URINARY TRACT INFECTION;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRECTOMY; GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE 1; HUMANS; ILEUM; INSULIN; JEJUNUM; LAPAROSCOPY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; TRIGLYCERIDES;

EID: 56349126813     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-008-9808-0     Document Type: Article

References (28)

1. GM Reaven 1988 Banting lecture 1988: role of insulin resistance in human disease Diabetes 37 1595 1607
2. Alexander CM, Landsman PB, Teutsch SM, Haffner SM Third National Health and Nutrition Examination Survey (NHANES III), National Cholesterol Education Program (NCEP) (2003) NCEP-Defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52(5):1210-1214
3. World Health Organization (1999) Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation. World Health Organization, Geneva
4. Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001 Executive summary of the third report of the National Cholesterol Education Program (NCEP). Adult Treatment Panel III JAMA 285 2486 2497
5. B Balkau MA Charles T Drivsholm K Borch-Johnsen N Wareham JS Yudkin R Morris I Zavaroni R van Dam E Feskins R Gabriel M Diet P Nilsson B Hedblad European Group For The Study of Insulin Resistance (EGIR) 2002 Frequency of the WHO metabolic syndrome in European cohorts and an alternative definition of an insulin resistance syndrome Diabetes Metab 28 364 376
6. D Einhorn GM Reaven RH Cobin E Ford OP Ganda Y Handelsman R Hellman PS Jellinger D Kendall RM Krauss ND Neufeld SM Petak HW Rodbard JA Seibel DA Smith PW Wilson 2003 American College of Endocrinology position statement on the insulin resistance syndrome Endocr Pract 9 237 252
7. ES Ford WH Giles 2003 A comparison of the prevalence of the metabolic syndrome using two proposed definitions Diabetes Care 26 575 581
8. American Diabetes Association 2004 Prevention or delay of type 2 diabetes Diabetes Care 27 Suppl 1 S47 S53
9. NB Watts RG Spanheimer M DiGirolamo SS Gebhart VC Musey YK Siddiq LS Phillips 1990 Prediction of glucose response to weight loss in patients with non-insulin-dependent diabetes mellitus Arch Intern Med 151 198 201
10. MS Hickey WJ Pories KG MacDonald Jr KA Cory GL Dohm MS Swanson RG Israel HA Barakat RV Considine JF Caro JA Houmard 1998 A new paradigm for type 2 diabetes mellitus? Could it be a disease of the foregut Ann Surg 227 637 644
11. SE Greenway FL Greenway S Klein 2002 Effects of obesity surgery on non-insulin-dependent diabetes mellitus Arch Surg 137 1109 1117
12. AL De Paula AL Macedo AS Prudente L Queiroz V Schraibman J Pinus 2006 Laparoscopic sleeve gastrectomy with ileal interposition ("neuroendocrine brake"): pilot study of a new operation Surg Obes Relat Dis 2 464 467
13. SM Grundy B Brewer Jr JI Cleeman SC Smith Jr. C Lenfant 2004 Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition Circulation 109 433 438
14. 2. Obes Surg 17:185-192
15. H Zhou Y Yamada K Tsukiyama K Miyawaki M Hosokawa K Nagashima K Toyoda R Naitoh W Mizunoya T Fushiki T Kadowaki Y Seino 2005 Gastric inhibitory polypeptide modulates adiposity and fat oxidation under diminished insulin action Biochem Biophys Res Commun 335 937 942
16. A Onat K Ceyhan O Basar B Erer S Toprak V Sansoy 2002 Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels: a prospective and cross-sectional evaluation Atherosclerosis 165 285 292
17. A Laws GM Reaven 1992 Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations J Intern Med 231 25 30
18. LD Lindholm H Ibsen B Dahlof RB Devereux G Beever U de Faire F Fyhrquist S Julius SE Kjeldsen K Kristiansson O Kederballe-Pedersen MS Niemine P Omvik S Oparil H Wedel P Aurup J Edelman S Snapin 2002 Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint Reduction in Hypertension Study (LIFE): a randomized trial against atenolol Lancet 359 1004 1010
19. UK Prospective Diabetes Study Group 1998 Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS38 BMJ 317 703 713
20. SE Stern K Williams E Ferrannini RA DeFronzo C Bogardus MP Stern 2005 Identification of individuals with insulin resistance using routine clinical measurements Diabetes 54 333 339
21. E Ferrannini B Balkau 2002 Insulin: in search of a syndrome Diabet Med 19 724 729
22. R Kahn J Buse E Ferrannini M Stern 2005 The metabolic syndrome: time for a critical appraisal: Joint Statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 28 2289 2303
23. E Rask T Olsson S Soderberg JJ Holst A Tura G Pacini B Ahrén 2004 Insulin secretion and incretin hormones after oral glucose in nonobese subjects with impaired glucose tolerance Metabolism 53 624 631
24. PM Ridker JE Buring NR Cook N Rifai 2003 C-reactive protein: the metabolic syndrome and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women Circulation 107 391 397
25. Pearson TA, Mensah GA (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499-511
26. C Weyer T Funahashi S Tanaka K Hotta Y Matsuzawa RE Pratley PA Tataranni 2000 Hypoadinoponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia J Clin Endocrinol Metab 86 1930 1935
27. M Chandran SA Phillips T Ciaraldi RR Henry 2003 Adiponectin: more than just another fat cell hormone Diabetes Care 26 2442 2450
28. JP Garg GL Bakris 2002 Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease Vasc Med 7 35 43